MANUFACTURING METHOD FOR HEN'S EGG IMPROVED IN QUALITY von MORINO, Miyabi, NAKAYAMA, Ayano, ARIYASU, Satoru, OTSUKI, Maho, SENOO, Satoko, FUJII, Toru, FUKANO, Natsuki, MITSUDA, Yoshino, FUKUDA, Yuma, NAKANISHI, Yuma, MORIMOTO, Mio

Volltext bestellen

MANUFACTURING METHOD FOR HEN'S EGG IMPROVED IN QUALITY von MITSUDA, YOSHINO, FUKANO, NATSUKI, OTSUKI, MAHO, FUJII, TORU, SENOO, SATOKO, MORINO, MIYABI, NAKANISHI, YUMA, FUKUDA, YUMA, NAKAYAMA, AYANO, MORIMOTO, MIO, ARIYASU, SATORU

Volltext bestellen

Barcode sequencing identifies resistant mechanisms to epidermal growth factor receptor inhibitors in circulating tumor DNA of lung cancer patients von Kitazono, Satoru, Sakai, Kazuko, Yanagitani, Noriko, Ariyasu, Ryo, Yoshizawa, Takahiro, Dotsu, Yosuke, Koyama, Junji, Saiki, Masafumi, Sonoda, Tomoaki, Nishikawa, Shingo, Uchibori, Ken, Horiike, Atsushi, Nishio, Kazuto, Nishio, Makoto

Volltext

Phase II study of the combination of S-1 with bevacizumab for patients with previously treated advanced non-squamous non-small-cell lung cancer von Hasegawa, Tsukasa, Yanagitani, Noriko, Ohyanagi, Fumiyoshi, Kudo, Keita, Horiike, Atsushi, Tambo, Yuichi, Nishikawa, Shingo, Ariyasu, Ryo, Uchibori, Ken, Kitazono, Satoru, Nishio, Makoto

Volltext

Monitoring epidermal growth factor receptor C797S mutation in Japanese non–small cell lung cancer patients with serial cell‐free DNA evaluation using digital droplet PCR von Ariyasu, Ryo, Uchibori, Ken, Sasaki, Takaaki, Tsukahara, Mika, Kiyotani, Kazuma, Yoshida, Ryohei, Ono, Yusuke, Kitazono, Satoru, Ninomiya, Hironori, Ishikawa, Yuichi, Mizukami, Yusuke, Yanagitani, Noriko, Fujita, Naoya, Nishio, Makoto, Katayama, Ryohei

Volltext

Advances in the treatment of postoperative recurrence of non–small cell lung cancer and their impact on survival in Asian patients von Hashimoto, Kohei, Ariyasu, Ryo, Ichinose, Junji, Matsuura, Yosuke, Nakao, Masayuki, Amino, Yoshiaki, Uchibori, Ken, Kitazono, Satoru, Yanagitani, Noriko, Okumura, Sakae, Nishio, Makoto, Mun, Mingyon

Volltext

Microsecond-timescale MD simulation of EGFR minor mutation predicts the structural flexibility of EGFR kinase core that reflects EGFR inhibitor sensitivity von Yoshizawa, Takahiro, Uchibori, Ken, Araki, Mitsugu, Matsumoto, Shigeyuki, Ma, Biao, Kanada, Ryo, Seto, Yosuke, Oh-hara, Tomoko, Koike, Sumie, Ariyasu, Ryo, Kitazono, Satoru, Ninomiya, Hironori, Takeuchi, Kengo, Yanagitani, Noriko, Takagi, Satoshi, Kishi, Kazuma, Fujita, Naoya, Okuno, Yasushi, Nishio, Makoto, Katayama, Ryohei

Volltext

EGFR-TKI re-administration after osimertinib failure in T790M mutation loss cases with re-biopsy von Ogusu, Shinsuke, Ariyasu, Ryo, Akita, Takahiro, Kiritani, Ayu, Tsugitomi, Ryosuke, Amino, Yoshiaki, Uchibori, Ken, Kitazono, Satoru, Yanagitani, Noriko, Nishio, Makoto

Volltext

Correlation between serum adenosine deaminase activity and efficacy of anti-programmed cell death-1 antibody von Saiki, Masafumi, Yoshizawa, Takahiro, Dotsu, Yosuke, Ariyasu, Ryo, Koyama, Junji, Sonoda, Tomoaki, Uchibori, Ken, Nishikawa, Shingo, Kitazono, Satoru, Yanagitani, Noriko, Horiike, Atsushi, Nishio, Makoto

Volltext

Dramatic response to alectinib in inflammatory myofibroblastic tumor with anaplastic lymphoma kinase fusion gene von Saiki, Masafumi, Ohyanagi, Fumiyoshi, Ariyasu, Ryo, Koyama, Junji, Sonoda, Tomoaki, Nishikawa, Shingo, Kitazono, Satoru, Yanagitani, Noriko, Horiike, Atsushi, Ninomiya, Hironori, Ishikawa, Yuichi, Nishio, Makoto

Volltext

Adrenal Insufficiency Related to Anti-Programmed Death-1 Therapy von Ariyasu, Ryo, Horiike, Atsushi, Yoshizawa, Takahiro, Dotsu, Yosuke, Koyama, Junji, Saiki, Masafumi, Sonoda, Tomoaki, Nishikawa, Shingo, Kitazono, Satoru, Yanagitani, Noriko, Nishio, Makoto

Volltext

MO45-3 The efficacy of osimertinib in patients with EGFR-positive non-small cell lung cancer with malignant pleural effusion von Kiritani, Ayu, Amino, Yoshiaki, Uchibori, Ken, Akita, Takahiro, Harutani, Yuhei, Ogusu, Shinsuke, Tsugitomi, Ryosuke, Manabe, Ryo, Ariyasu, Ryo, Kitazono, Satoru, Yanagitani, Noriko, Nishio, Makoto

Volltext

High ratio of T790M to EGFR activating mutations correlate with the osimertinib response in non-small-cell lung cancer von Ariyasu, Ryo, Nishikawa, Shingo, Uchibori, Ken, Oh-hara, Tomoko, Yoshizawa, Takahiro, Dotsu, Yosuke, Koyama, Junji, Saiki, Masafumi, Sonoda, Tomoaki, Kitazono, Satoru, Yanagitani, Noriko, Horiike, Atsushi, Inase, Naohiko, Kasahara, Kazuo, Nishio, Makoto, Katayama, Ryohei

Volltext

Distinction of ALK fusion gene‐ and EGFR mutation‐positive lung cancer with tumor markers von Akita, Takahiro, Ariyasu, Ryo, Kakuto, Sho, Miyadera, Keiki, Kiritani, Ayu, Tsugitomi, Ryosuke, Amino, Yoshiaki, Uchibori, Ken, Kitazono, Satoru, Yanagitani, Noriko, Tasaka, Sadatomo, Nishio, Makoto

Volltext

Efficacy of osimertinib in patients with EGFR‐mutation positive non‐small cell lung cancer with malignant pleural effusion von Kiritani, Ayu, Amino, Yoshiaki, Uchibori, Ken, Akita, Takahiro, Harutani, Yuhei, Ogusu, Shinsuke, Tsugitomi, Ryosuke, Manabe, Ryo, Ariyasu, Ryo, Kitazono, Satoru, Yanagitani, Noriko, Nishio, Makoto

Volltext

Improvement in the survival of patients with stage IV non-small-cell lung cancer: Experience in a single institutional 1995–2017 von Takano, Natsuki, Ariyasu, Ryo, Koyama, Junji, Sonoda, Tomoaki, Saiki, Masafumi, Kawashima, Yosuke, Oguri, Tomoyo, Hisakane, Kakeru, Uchibori, Ken, Nishikawa, Shingo, Kitazono, Satoru, Yanagitani, Noriko, Ohyanagi, Fumiyoshi, Horiike, Atsushi, Gemma, Akihiko, Nishio, Makoto

Volltext

Soluble interleukin-2 receptor as a predictive biomarker for poor efficacy of combination treatment with anti-PD-1/PD-L1 antibodies and chemotherapy in non-small cell lung cancer p... von Tozuka, Takehiro, Yanagitani, Noriko, Yoshida, Hiroshi, Manabe, Ryo, Ogusu, Shinsuke, Tsugitomi, Ryosuke, Sakamoto, Hiroaki, Amino, Yoshiaki, Ariyasu, Ryo, Uchibori, Ken, Kitazono, Satoru, Seike, Masahiro, Gemma, Akihiko, Nishio, Makoto

Volltext

Clinical characteristics of patients with KRAS mutation detected by liquid biopsy von Amino, Yoshiaki, Low, Siew‐Kee, Ninomiya, Hironori, Kiritani, Ayu, Miyadera, Keiki, Kakuto, Sho, Akita, Takahiro, Tsugitomi, Ryosuke, Ariyasu, Ryo, Uchibori, Ken, Kitazono, Satoru, Yanagitani, Noriko, Nishio, Makoto

Volltext

Efficacy of EGFR tyrosine kinase inhibitors in patients having EGFR-activating mutations with or without BIM polymorphisms von Ariyasu, Ryo, Yanagitani, Noriko, Tadokoro, Kenichi, Yamaguchi, Toshikazu, Uchibori, Ken, Kitazono, Satoru, Fujita, Naoya, Katayama, Ryohei, Nishio, Makoto

Volltext

Feasibility of next‐generation sequencing test for patients with advanced NSCLC in clinical practice von Ariyasu, Ryo, Uchibori, Ken, Ninomiya, Hironori, Ogusu, Shinsuke, Tsugitomi, Ryosuke, Manabe, Ryo, Sakamaoto, Hiroaki, Tozuka, Takehiro, Yoshida, Hiroshi, Amino, Yoshiaki, Kitazono, Satoru, Yanagitani, Noriko, Takeuchi, Kengo, Nishio, Makoto

Volltext